2TZ Stock Overview
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥1.82 |
| 52 Week High | CN¥2.14 |
| 52 Week Low | CN¥1.52 |
| Beta | 0.70 |
| 1 Month Change | -0.89% |
| 3 Month Change | 12.83% |
| 1 Year Change | -4.58% |
| 3 Year Change | 151.74% |
| 5 Year Change | 115.12% |
| Change since IPO | 145.72% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2TZ | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -0.8% | 3.2% | 1.7% |
| 1Y | -4.6% | -28.2% | 2.3% |
Return vs Industry: 2TZ exceeded the German Pharmaceuticals industry which returned -27.7% over the past year.
Return vs Market: 2TZ underperformed the German Market which returned 2.2% over the past year.
Price Volatility
| 2TZ volatility | |
|---|---|
| 2TZ Average Weekly Movement | 3.7% |
| Pharmaceuticals Industry Average Movement | 6.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 2TZ has not had significant price volatility in the past 3 months.
Volatility Over Time: 2TZ's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 4,619 | Lei Wang | www.jydrt.com.cn |
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; and biochemical pharmaceutical products, as well as wholesale and retail sale of medicines. Its products include Suxiao Jiuxin Pills, Jingwanhong Ointment, Biqi Capsules, Shunaoxin Dropping Pills, Zilongjin Tablets, Qingfei Xiaoyan Pills, Huoxiangzhengqi Soft Capsules, Tongmai Yangxin Pills, Weichangan Pills, Qingyan Dropping Pills, Haima Bushen Pills, Angong Niuhuang Pills, Niuhuang Qingxin Pills, Qinggong Shoutao Pills, etc. The company also engages in pharmaceutical commercial logistic services; pharmaceuticals retail; chemical raw materials and preparations; and biomedicine.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Fundamentals Summary
| 2TZ fundamental statistics | |
|---|---|
| Market cap | €2.84b |
| Earnings (TTM) | €127.24m |
| Revenue (TTM) | €1.06b |
26.2x
P/E Ratio3.1x
P/S RatioIs 2TZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2TZ income statement (TTM) | |
|---|---|
| Revenue | CN¥8.22b |
| Cost of Revenue | CN¥4.63b |
| Gross Profit | CN¥3.59b |
| Other Expenses | CN¥2.60b |
| Earnings | CN¥986.71m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 30, 2024
| Earnings per share (EPS) | 1.28 |
| Gross Margin | 43.66% |
| Net Profit Margin | 12.00% |
| Debt/Equity Ratio | 5.0% |
How did 2TZ perform over the long term?
See historical performance and comparison